Cardiovascular Safety of Alogliptin: The EXAMINE Trial

Cardiovascular Safety of Alogliptin: The EXAMINE Trial

MP3

Interview with:

William B. White, MD, Professor of Medicine, and Head, Division of Hypertension and Clinical Pharma­cology, Calhoun Cardiology Center, University of Connecticut, School of Medicine, Farmington, CT

EXAMINE trial

The Examination of Cardiovascular Outcomes: Alogliptin vs. Standard Care in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE) trial was completed in 2013.

In 2008, the Food and Drug Administra­tion (FDA) created specific requirements to rule out CV safety...